View by Specialty

Trending

PC1124Murray_Graphic_01_WEB
November 22, 2024
3 min read
Save

‘Truly alarming’: Life expectancy gap in the US now up to 20 years

Practice Management News

SPONSORED CONTENT
Save
SPONSORED CONTENT
December 01, 2022
1 min read
Save

Poverty linked to externalizing problems in early adolescence

Poverty linked to externalizing problems in early adolescence

Childhood poverty was associated with increases in externalizing problems, but not internalizing, over time in early adolescence, researchers reported in JAMA Network Open.

SPONSORED CONTENT
December 01, 2022
5 min read
Save

Some practices can benefit from a state tax strategy

Some practices can benefit from a state tax strategy

Practices may find this short primer on state pass-through entity election and year-end tax tips helpful to determine whether they can benefit from a state tax strategy or create some tax savings before Jan. 1, 2023.

Trending

PC1124Murray_Graphic_01_WEB
November 22, 2024
3 min read
Save

‘Truly alarming’: Life expectancy gap in the US now up to 20 years

SPONSORED CONTENT
November 30, 2022
3 min read
Save

Lecanemab reduces amyloid, slows cognitive decline in early Alzheimer’s disease

Lecanemab reduces amyloid, slows cognitive decline in early Alzheimer’s disease

Lecanemab reduced amyloid markers and slowed cognitive decline in patients with early Alzheimer’s disease, although not without risk for adverse events, according to new data published in The New England Journal of Medicine.

SPONSORED CONTENT
November 30, 2022
1 min read
Save

Phase 2 trial initiated for depression treatment targeting specific biomarker

Phase 2 trial initiated for depression treatment targeting specific biomarker

EmbarkNeuro, a neuroscience biotech company formerly known as Ancora Bio, announced its phase 2 trial is under way for ANC-501, a first-in-class vasopressin 1b receptor antagonist for the treatment of major depressive disorder.

SPONSORED CONTENT
November 30, 2022
1 min read
Save

Prenatal cannabis use more common in areas with greater retail availability

Prenatal cannabis use more common in areas with greater retail availability

Use of cannabis among individuals who are pregnant was more common among those living in areas with greater retail availability, researchers reported in JAMA Network Open.

SPONSORED CONTENT
November 29, 2022
2 min read
Save

Smokers who receive intervention in Spanish twice as likely to cease smoking

Smokers who receive intervention in Spanish twice as likely to cease smoking

Smokers who preferred receiving point-of-care services in Spanish were twice as likely to refrain from smoking cigarettes after 6 months compared with those who preferred English, researchers reported in Annals of Family Medicine.

SPONSORED CONTENT
November 29, 2022
1 min read
Save

HHS proposes new protections to boost care coordination, confidentiality for those with SUD

HHS proposes new protections to boost care coordination, confidentiality for those with SUD

HHS has proposed changes to a regulation that protects patient privacy and records concerning treatment related to substance use challenges from unauthorized disclosures. According to a release from HHS, the move was made through the Office for Civil Rights and SAMHSA.

SPONSORED CONTENT
November 28, 2022
1 min read
Save

Poll: 45% of Americans concerned about mental health during holidays

Poll: 45% of Americans concerned about mental health during holidays

According to a recently released survey, 45% of Americans are worried about their mental health this holiday season.

SPONSORED CONTENT
November 28, 2022
1 min read
Save

Posterior surgery noninferior to anterior for treating cervical radiculopathy

Posterior surgery noninferior to anterior for treating cervical radiculopathy

Posterior cervical foraminotomy was noninferior to anterior cervical discectomy with fusion in success rate and arm pain at 1 year in patients with cervical radiculopathy, researchers reported in JAMA Neurology.

SPONSORED CONTENT
November 28, 2022
1 min read
Save

Positive results announced in phase 3 study of intranasal esketamine for TRD

Positive results announced in phase 3 study of intranasal esketamine for TRD

Janssen has announced positive results from the phase 3 ESCAPE-TRD trial, which evaluated flexibly dosed intranasal esketamine for treatment-resistant major depressive disorder.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails